Filing Flows › Bio-Rad Laboratories (BIO) › Guidance history
Bio-Rad Laboratories (BIO) guidance history: what it guided and what it reported
Bio-Rad Laboratories gave guidance in 11 earnings releases on file since Feb 15, 2024. Its releases raised guidance once and lowered it once.
Adjusted operating margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 12.0%–12.5% (Feb 12, 2026) → lowered 10.0%–12.0% (Apr 30, 2026) → reaffirmed 10.0%–12.0% (Aug 4, 2026) → reaffirmed 10.0%–12.0% (Nov 4, 2026) | — | to be reported | — |
| FY2025 | 13.0%–13.5% (Feb 13, 2025) → lowered 10.0%–12.0% (May 1, 2025) → raised 12.0%–13.0% (Jul 31, 2025) → reaffirmed 12.0%–13.0% (Oct 29, 2025) | — | — | — |
| FY2024 | 13.5%–14.0% (Feb 15, 2024) → reaffirmed 13.5%–14.0% (May 7, 2024) → lowered 12.0%–13.0% (Aug 1, 2024) | — | — | — |
The latest quarter
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
Questions
Does Bio-Rad Laboratories beat its guidance?
Bio-Rad Laboratories gave guidance in 11 earnings releases on file since Feb 15, 2024. Its releases raised guidance once and lowered it once.
How often does Bio-Rad Laboratories raise guidance?
Its earnings releases raised guidance once and lowered it once since Feb 15, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.